Some excellent news on the weight-loss entrance: Clients can now go to Costco to get Ozempic and Wegovy, brand-name injectable pharmaceuticals manufactured by drugmaker Novo Nordisk, which comprise the identical lively ingredient: semaglutide.
The Danish pharmaceutical agency introduced Friday that each can be found on the big-box retailer’s pharmacies nationwide, for $499 for a month’s provide—the identical value as bought in CVS, Walmart, and the corporate’s direct-to-consumer web site. You’ll nonetheless want a prescription to purchase the medication.
Quick Firm has reached out to each Costco and Novo Nordisk for remark.
Additionally—Costco is providing a 2% low cost for Costco govt members and Costco Citibank Visa cardholders, in line with CBS Information.
The drugs are comparable however the Meals and Drug Administration has authorised them for 2 completely different causes. Wegovy is authorised for power weight administration. Ozempic is authorised for treating kind 2 diabetes and to cut back the chance of cardiovascular well being points together with coronary heart assault, stroke, and loss of life in individuals with kind 2 diabetes and coronary heart illness. Ozempic is prescribed “off-label” for weight reduction.
They’re administered in several dosages and reportedly have completely different unwanted effects. As a result of Wegovy is run at larger doses, a most of two.4 milligrams per week, it might result in better weight reduction but in addition extra gastrointestinal unwanted effects. Ozempic is often administered at 2 milligrams per week. Every are injected as soon as per week.
Costco financials
Costco Wholesale Corp. (COST) inventory was down lower than 1% throughout afternoon buying and selling on October 6.
The corporate reported fourth-quarter earnings for the interval ending August 31, 2025, with internet gross sales for the quarter up 8% to $84.4 billion (from $78.2 billion final yr). Internet gross sales for the fiscal yr elevated 8.1% to $269.9 billion (from $249.6 billion final yr).
Costco at present has a market capitalization of $402.6 billion.
